The results? A nasal spray of oxytocin significantly reduced acute feelings of loneliness in participants, especially during group therapy sessions, even months after treatment. In the study ...

🚨 Joint Venture Announcement 🚨 We’re thrilled to announce our newest joint venture with Guthrie, a health system with over a century of excellence in patient care. Starting March 1, 2025 ...

Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS).

He's using his talent to help others, and he's hoping you'll join him. "I'm principle trumpet of the Nashville Symphony," Will Leathers said. "I don't remember a day in my life that I didn't hear ...

Eli Lilly’s acquisition of gene therapy specialist Akouos seems to have paid off, after the lead candidate in the deal restored hearing in a child with congenital deafness. The AK-OTOF therapy ...